Analyst favorites stocks: what the screen found on November 22, 2026
Manufacturing dominates the latest results, accounting for 28 of the 40 companies that passed the screen on November 20, 2026. This concentration suggests a narrow focus rather than a broad market spread.
Key figures
Data as of Nov 22, 2026- IMUX (Immunic, Inc. Common Stock) market cap
- $111.72M
- CSTL (Castle Biosciences, Inc. Common Stock) market cap
- $1.01B
- MMYT (MakeMyTrip Limited) market cap
- $4.50B
- AVBP (ArriVent BioPharma, Inc. Common Stock) market cap
- $546.20M
- FWRG (First Watch Restaurant Group, Inc. Common Stock) market cap
- $720.97M
- OVID (Ovid Therapeutics Inc. Common Stock) market cap
- $418.98M
Manufacturing dominates the latest results, accounting for 28 of the 40 companies¹˒² that passed the screen on November 20, 2026. This concentration suggests a narrow focus rather than a broad market spread.
The list includes companies with varying market caps and analyst ratings of 1.0³. These range from smaller firms like Immunic, Inc. ($111.72M⁴) and Ovid Therapeutics Inc. ($418.98M⁵) to larger entities such as Castle Biosciences, Inc. ($1.01B⁶) and MakeMyTrip Limited ($4.50B⁷). ArriVent BioPharma, Inc. ($546.20M⁸) and First Watch Restaurant Group, Inc. ($720.97M⁹) also appear. Recent activity includes SEC filings from several of these names, such as quarterly reports from Immunic, Inc., ArriVent BioPharma, Inc., and Ovid Therapeutics Inc..
Every company on this list passed a test for strong-buy-leaning consensus from multiple analysts, with a median rating of 1.1¹⁰. However, passing this specific filter does not establish that a company is a good investment or is worth owning. Because analyst crowds are documented to skew bullish, this result serves as a starting list for further research rather than a final verdict on a stock's value.
Educational tool. Not investment advice. This article was produced with automated assistance. Every figure in it was checked against the underlying data before it was published; the interpretation was not.